FDA Inspection
Grifols Therapeutics LLCGrifols Therapeutics LLC – FDA Inspection, Feb 10, 2017
Record Details
This FDA Inspection record concerns Grifols Therapeutics LLC, with an inspection on February 10, 2017, issued by the Atlanta District Office, covering biologics.
- Office
- Atlanta District Office
- People
- Bradley J. Dworak
- Richard H. Coats (Issuing Officer)
- Wei Wang (Company Rep)
View Company Profile
ID · cd7b9835-ca8b-4844-95da-18ed498be896
Inspection Facts
- Inspection number
- 1003199
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Grifols Therapeutics LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| September 1, 2023 | Not classified | Atlanta District Office | |
| May 6, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 13, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 21, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Therapeutics LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.